[HTML][HTML] Folliculin: a regulator of transcription through AMPK and mTOR signaling pathways

JMJ Ramirez Reyes, R Cuesta… - Frontiers in Cell and …, 2021 - frontiersin.org
Folliculin (FLCN) is a tumor suppressor gene responsible for the inherited Birt-Hogg-Dubé
(BHD) syndrome, which affects kidneys, skin and lungs. FLCN is a highly conserved protein …

Recruitment of folliculin to lysosomes supports the amino acid–dependent activation of Rag GTPases

CS Petit, A Roczniak-Ferguson, SM Ferguson - Journal of Cell Biology, 2013 - rupress.org
Birt-Hogg-Dubé syndrome, a human disease characterized by fibrofolliculomas (hair follicle
tumors) as well as a strong predisposition toward the development of pneumothorax …

[HTML][HTML] Nutrient signaling and lysosome positioning crosstalk through a multifunctional protein, folliculin

N de Martín Garrido, CHS Aylett - Frontiers in Cell and …, 2020 - frontiersin.org
FLCN was identified as the gene responsible for Birt-Hogg-Dubé (BHD) syndrome, a
hereditary syndrome associated with the appearance of familiar renal oncocytomas. Most …

Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling

M Baba, SB Hong, N Sharma… - Proceedings of the …, 2006 - National Acad Sciences
Birt–Hogg–Dubé syndrome, a hamartoma disorder characterized by benign tumors of the
hair follicle, lung cysts, and renal neoplasia, is caused by germ-line mutations in the BHD …

FLCN: the causative gene for Birt-Hogg-Dubé syndrome

LS Schmidt, WM Linehan - Gene, 2018 - Elsevier
Germline mutations in the novel tumor suppressor gene FLCN are responsible for the
autosomal dominant inherited disorder Birt-Hogg-Dubé (BHD) syndrome that predisposes to …

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis

C Di Malta, A Zampelli, L Granieri, C Vilardo… - EMBO Molecular …, 2023 - embopress.org
Abstract Birt‐Hogg‐Dubé (BHD) syndrome is an inherited familial cancer syndrome
characterized by the development of cutaneous lesions, pulmonary cysts, renal tumors and …

Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies

LS Schmidt - Familial cancer, 2013 - Springer
Since the hallmark dermatologic features of Birt–Hogg–Dubé (BHD) syndrome were first
described by three Canadian physicians in 1977, the clinical manifestations of BHD have …

The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue

S Wada, M Neinast, C Jang, YH Ibrahim… - Genes & …, 2016 - genesdev.cshlp.org
Noncanonical mechanistic target of rapamycin (mTOR) pathways remain poorly understood.
Mutations in the tumor suppressor folliculin (FLCN) cause Birt-Hogg-Dubé syndrome, a …

[HTML][HTML] Tumor suppressor folliculin regulates mTORC1 through primary cilia

M Zhong, X Zhao, J Li, W Yuan, G Yan, M Tong… - Journal of Biological …, 2016 - ASBMB
Folliculin (FLCN) is the tumor suppressor associated with Birt-Hogg-Dubé (BHD) syndrome
that predisposes patients to incident of hamartomas and cysts in multiple organs. Its …

Identification and characterization of a novel folliculin-interacting protein FNIP2

H Hasumi, M Baba, SB Hong, Y Hasumi, Y Huang… - Gene, 2008 - Elsevier
Birt–Hogg–Dube'syndrome characterized by increased risk for renal neoplasia is caused by
germline mutations in the BHD/FLCN gene encoding a novel tumor suppressor protein …